US Stock MarketDetailed Quotes
PULM Pulmatrix
- 1.896
- +0.006+0.29%
Trading May 8 11:07 ET
6.92MMarket Cap-489P/E (TTM)
1.950High1.896Low1.59KVolume1.890Open1.890Pre Close3.06KTurnover0.04%Turnover RatioLossP/E (Static)3.65MShares2.91052wk High0.38P/B6.92MFloat Cap1.55052wk Low--Dividend TTM3.65MShs Float4235.000Historical High--Div YieldTTM2.88%Amplitude1.550Historical Low1.928Avg Price1Lot Size
About Pulmatrix Company
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the development and discovery of novel inhaled therapeutics products. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov, and Robert S. Langer, Jr. in April 2003 and is headquartered in Bedford, MA.
Company Profile
SymbolPULM
Company NamePulmatrix
Listing DateMar 21, 2014
Founded2003
CEOMr. Teofilo David Raad
MarketNASDAQ
Employees22
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address36 Crosby Drive,Suite 100
CityBedford
ProvinceMassachusetts
CountryUnited States of America
Zip Code01730
Phone1-781-357-2333
Websitehttp://www.pulmatrix.com
Company Executives
- Name
- Position
- Salary
- Teofilo David Raad
- Chief Executive Officer, President and Director
- 1.01M
- Peter Ludlum
- Interim Chief Financial Officer and Principal Accounting Officer
- 398.58K
- Michael J. Higgins
- Chairman of the Board
- 96.53K
- Todd Bazemore
- Independent Director
- 59.41K
- Anand Varadan
- Independent Director
- 46.91K
- Christopher Cabell, M.D.
- Independent Director
- 51.91K
- Dr. Richard P. Batycky, PhD
- Independent Director
- 60.91K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg